N-terminal-pro-B-type natriuretic peptide in acute hyperthyroidism

Thyroid

Volumn 17, Issue 3, 2007, Pages 237-241

  Schultz, Marianne ^a   Kistorp, Caroline ^b   Langdahl, Bente ^c   Raymond, Ilan ^a   Hildebrandt, Per ^d   Faber, Jens ^b  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d ROSKILDE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; LIOTHYRONINE; THYROTROPIN;

ADULT; AGED; ARTICLE; FEMALE; FREE LIOTHYRONINE INDEX; HEART RATE; HEART WORK; HUMAN; HUMAN EXPERIMENT; HYPERTHYROIDISM; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SYSTOLIC HEART FAILURE; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; WEIGHT REDUCTION;

ACUTE DISEASE; AGED; FEMALE; HUMANS; HYPERTHYROIDISM; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDES; REGRESSION ANALYSIS; THYROID FUNCTION TESTS; THYROTROPIN; TIME FACTORS; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 34147185188     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2006.0258     Document Type: Article

References (28)

1. Baughman KL 2002 B-type natriuretic peptide-a window to the heart. N Engl J Med 347:158-159.
2. Clerico A, Iervasi G, Del Chicca MG, Emdin M, Maffei S, Nannipieri M, Sabatino L, Forini F, Manfredi C, Donato L 1998 Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 21:170-179.
3. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, Nishino K, Yoshimasa T, Nakao K 1995 Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 96:1280-1287.
4. Pemberton CJ, Johnson ML, Yandle TG, Espiner EA 2000 Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 36:355-359.
5. Hammerer-Lercher A, Neubauer E, Muller S, Pachinger O, Puschendorf B, Mair J 2001 Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 310: 193-197.
6. Hunt PJ, Richards AM, Nicholls MG, Yandle TG, Doughty RN, Espiner EA 1997 Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol 47:287-296.
7. Richards AM, Doughty R, Nicholls MG, MacMahon S, Sharpe N, Murphy J, Espiner EA, Frampton C, Yandle TG 2001 Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol 37:1781-1787.
8. Schultz M, Faber J, Kistorp C, Jarlov A, Pedersen F, Wiinberg N, Hildebrandt P 2004 N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states. Clin Endocrinol 60:54-59.
9. Liang F, Webb P, Marimuthu A, Zhang S, Gardner DG 2003 Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes. J Biol Chem 278:15073-15083.
10. Kohno M, Horio T, Yasunari K, Yokokawa K, Ikeda M, Kurihara N, Nishizawa Y, Morii H, Takeda T 1993 Stimulation of brain natriuretic peptide release from the heart by thyroid hormone. Metabolism 42:1059-1064.
11. Langdahl BL, Loft AG, Moller N, Weeke J, Eriksen EF, Mosekilde L, Charles P 1996 Skeletal responsiveness to thyroid hormone is not altered at menopause. Bone 19:557-564.
12. Langdahl BL, Loft AG, Moller N, Weeke J, Eriksen EF, Mosekilde L, Charles P 1997 Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy? J Bone Miner Res 12: 78-88.
13. Weeke J, Orskov H 1975 Ultrasensitive radioimmunoassay for direct determination of free triiodothyronine concentration in serum. Scan J Clin Lab Invest 35:237-244.
14. Carr D, McLeod DT, Parry G, Thornes HM 1988 Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol 28:325-333.
15. Faber J, Wiinberg N, Schifter S, Mehlsen J 2001 Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur J Endocrinol 145:391-396.
16. Faber J, Petersen L, Wiinberg N, Schifter S, Mehlsen J 2002 Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism. Thyroid 12:319-324.
17. Andersen S, Pedersen KM, Bruun NH, Laurberg P 2002 Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87:1068-1072.
18. Klein I, Levey GS 1996 The cardiovascular system in thyrotoxicosis. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid. Lippincott-Raven Publisher, Philadelphia, pp 607-615.
19. Klein I, Ojamaa K 1996 The cardiovascular system in hypothyroidism. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid. Lippincott-Raven Publisher, Philadelphia, pp 799-804.
20. LaPointe MC 2005 Molecular regulation of the brain natriuretic peptide gene. Peptides 26:944-956.
21. Foote RS, Pearlman JD, Siegel AH, Yeo KT 2004 Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 44:1980-1987.
22. Huang WS, Lee MS, Perng HW, Yang SP, Kuo SW, Chang HD 2002 Circulating brain natriuretic peptide values in healthy men before and after exercise. Metabolism 51:1423-1426.
23. Konig D, Schumacher YO, Heinrich L, Schmid A, Berg A, Dickhuth HH 2003 Myocardial stress after competitive exercise in professional road cyclists. Med Sci Sports Exerc 35:1679-1683.
24. Wei T, Zeng C, Tian Y, Chen Q, Wang L 2005 B-type natriuretic peptide in patients with clinical hyperthyroidism. J Endocrinol Invest 28:8-11.
25. Mair J 2002 Role of cardiac natriuretic peptide testing in heart failure. Clin Chem 48:977-978.
26. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, Buttimore RC, Lainchbury JG, Elliott JM, Ikram H, Crozier IG, Smyth DW 1998 Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97: 1921-1929.
27. Lainchbury JG, Richards AM, Nicholls MG, Hunt PJ, Ikram H, Espiner EA, Yandle TG, Begg E 1997 The effects of pathophysiological increments in brain natriuretic peptide in left ventricular systolic dysfunction. Hypertension 30:398-404.
28. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P 2005 N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293:1609-1616.